Table 1.
All patients N=2043 |
Had none of outcomes N=1454 |
Had at least one outcome N=589 |
|
---|---|---|---|
Demographics, % | |||
Age – Years, mean (SD) | 82.0 (7.4) | 81.6 (7.4) | 83.0 (7.2) |
Male | 36.0 | 33.6 | 42.1 |
White race | 89.9 | 90.7 | 87.8 |
Married | 33.2 | 32.8 | 34.4 |
Household income <$25,000 | 64.6 | 63.6 | 67.1 |
Comorbidities, % | |||
Barthel index, mean (SD) | 37.1 (22.9) | 41.9 (22.2) | 25.3 (20.0) |
Charlson comorbidity score, mean (SD) | 0.7 (1.3) | 0.6 (1.1) | 1.0 (1.6) |
Body mass index, mean (SD) | 26.1 (6.5) | 26.5 (6.4) | 25.0 (6.7) |
Dementia | 18.9 | 16.2 | 25.6 |
Heart failure | 22.5 | 18.9 | 31.2 |
Hospital length of stay – days, mean (SD) | 10.3 (11.0) | 9.1 (9.0) | 13.3 (14.5) |
Active conditions at SNF admission, % | |||
Cognitive impairment | |||
None/borderline | 66.4 | 70.5 | 56.0 |
Moderate | 15.0 | 14.8 | 15.7 |
Severe | 18.6 | 14.7 | 28.3 |
Delirium | 9.4 | 7.2 | 15.0 |
Dyspnea | 7.9 | 5.9 | 12.9 |
Edema | 37.6 | 36.7 | 39.7 |
Pressure ulcer | 18.0 | 14.4 | 26.7 |
Frequent pain | 33.7 | 35.7 | 28.6 |
Treatments at SNF admission, % | |||
Antianxiety or hypnotic medication | 26.9 | 26.5 | 29.1 |
Antipsychotic medication | 8.8 | 7.0 | 13.1 |
Indwelling catheter | 2175 | 17.8 | 31.4 |
Feeding tube | 3.4 | 1.2 | 8.9 |
Intravenous medications | 59.2 | 57.6 | 63.2 |
Oxygen | 33.0 | 29.5 | 41.7 |
SNF characteristics, % | |||
Ownership | |||
For-profit | 63.2 | 61.4 | 67.6 |
Government | 3.2 | 3.1 | 3.4 |
Not for-profit | 33.1 | 34.9 | 28.7 |
Size (beds) | |||
1–77 | 25.4 | 27.2 | 20.9 |
78–121 | 34.0 | 32.7 | 37.4 |
122–154 | 16.0 | 16.0 | 16.0 |
154–889 | 24.7 | 24.2 | 25.8 |
Results for other variables included in the predictive modeling are listed in Supplemental Table S2.